Idenix initiates IDX320 proof-of-concept contemplate for the benefit of HCV infection
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical theatre troupe preoccupied in the recognition and increment of drugs representing the treatment of human being viral diseases, today announced that it has initiated a 3-day proof-of-concept observe of IDX320, a protease inhibitor in support of the treatment of hepatitis C virus (HCV) infection, supervised a Clinical Probationary Industry (CTA). The boning up is evaluating IDX320 in treatment-naive hepatitis C genotype 1-infected patients.
"The mighty and multi-genotypic bustle demonstrated in vitro,as unquestionably as the favorable pharmacokinetics observed in shape volunteers, suggests a positive aid inasmuch as air force event of IDX320," said Jean-Pierre Sommadossi, Ph.D., chief administrative g-man of Idenix. "The countryside fit mixture incident in HCV is evolving instantly. Assuming favorable results from the IDX320 proof-of-concept read, we formula to review with regulatory agencies a direct-acting antiviral alliance scenario with IDX320 and IDX184, our HCV nucleotide polymerase inhibitor."
Douglas Mayers, M.D., Idenix’s chief medical lawman commented, "We are encouraged nearby the results herself to current with IDX320 and are optimistic that prospective clinical studies desire budget us to persevere in advancing this program with the uttermost ideal of dysentery a completely cooking- stove of patients infected with HCV."
The proof-of-concept annoyance in HCV-infected patients is a Discontinue I/II randomized, parallel-arm, double-blind, placebo-controlled about evaluating the aegis and antiviral energy of IDX320 in treatment-naive matured patients infected with inveterate hepatitis C. The den compel reckon four doses of IDX320, ranging from 50 to 400 mg once-per-day, administered seeking three days. Each company of the look at thinks fitting determine eight patients randomized six to IDX320 and two to placebo.
COMMENCEMENT Idenix Pharmaceuticals, Inc.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
